NCT00950248: Clinical Trial of Idebenone in Primary Progressive Multiple Sclerosis (IPPoMS) |
|
|
| Completed | 1/2 | 85 | US | Idebenone, SNT-MC17/F02, placebo, SNT-MC17/F03 | National Institute of Allergy and Infectious Diseases (NIAID) | Primary Progressive Multiple Sclerosis | 04/18 | 08/18 | | |
